Skip links

Targeting the Mesenchymal Cancer Cell Phenotype for Therapeutic Gain

Project summary

Most cancer patients die from malignant metastases, or because the patients have become insensitive to chemotherapy. In this project, we aim to identify and repurpose existing drugs to selectively change the behaviour of aggressive cancer cells into non-invasive and therapy sensitive cancer cells or benign fat cells.

Impact

Type the project impact here.

More detailed information

Principal Investigator:

Prof. J.W.M. (John) Martens and prof. S. (Stefan) Sleijfer

Role Erasmus MC:

Partner

Department:

Department

Project website:

Not available

Funding Agency:

ZonMw